ARTICLE | Distillery Therapeutics
An inhibitor of the ALOX12-ACACA interaction for NASH
February 11, 2022 9:00 PM UTC
DISEASE CATEGORY: Hepatic
INDICATION: Non-alcoholic steatohepatitis (NASH)...
BCIQ Company Profiles
DISEASE CATEGORY: Hepatic
INDICATION: Non-alcoholic steatohepatitis (NASH)...
BCIQ Company Profiles
BCIQ Company Profiles